TOFACITINIB (TOFACITINIB CITRATE) — all Canadian products
18 DINs
16 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TOFACITINIB (TOFACITINIB CITRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02538261 | APO-TOFACITINIB | APOTEX INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Approved | |
| 02538253 | APO-TOFACITINIB | APOTEX INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Approved | |
| 02530007 | AURO-TOFACITINIB | AURO PHARMA INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Marketed | |
| 02530015 | AURO-TOFACITINIB | AURO PHARMA INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Marketed | |
| 02570181 | DEVATIS TOFACITINIB | DEVATIS CANADA INC. | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Approved | |
| 02570173 | DEVATIS TOFACITINIB | DEVATIS CANADA INC. | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Approved | |
| 02522896 | JAMP TOFACITINIB | JAMP PHARMA CORPORATION | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Marketed | |
| 02522799 | PMS-TOFACITINIB | PHARMASCIENCE INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Marketed | |
| 02551691 | SANDOZ TOFACITINIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Marketed | |
| 02551705 | SANDOZ TOFACITINIB | SANDOZ CANADA INCORPORATED | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Marketed | |
| 02511312 | TARO-TOFACITINIB | TARO PHARMACEUTICALS INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Marketed | |
| 02511304 | TARO-TOFACITINIB | TARO PHARMACEUTICALS INC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Marketed | |
| 02553988 | TARO-TOFACITINIB XR | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | Oral | TOFACITINIB (TOFACITINIB CITRATE) 11 MG | Marketed | |
| 02480786 | XELJANZ | PFIZER CANADA ULC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Marketed | |
| 02423898 | XELJANZ | PFIZER CANADA ULC | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Marketed | |
| 02470608 | XELJANZ XR | PFIZER CANADA ULC | Tablet (Extended-Release) | Oral | TOFACITINIB (TOFACITINIB CITRATE) 11 MG | Marketed | |
| 02544326 | TEVA-TOFACITINIB | TEVA CANADA LIMITED | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 10 MG | Cancelled Pre Market | |
| 02544318 | TEVA-TOFACITINIB | TEVA CANADA LIMITED | Tablet | Oral | TOFACITINIB (TOFACITINIB CITRATE) 5 MG | Cancelled Pre Market |
Browse other molecules: